219 related articles for article (PubMed ID: 2378882)
1. Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy.
Schwendener RA; Trüb T; Schott H; Langhals H; Barth RF; Groscurth P; Hengartner H
Biochim Biophys Acta; 1990 Jul; 1026(1):69-79. PubMed ID: 2378882
[TBL] [Abstract][Full Text] [Related]
2. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.
Koning GA; Morselt HW; Velinova MJ; Donga J; Gorter A; Allen TM; Zalipsky S; Kamps JA; Scherphof GL
Biochim Biophys Acta; 1999 Aug; 1420(1-2):153-67. PubMed ID: 10446299
[TBL] [Abstract][Full Text] [Related]
3. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
Mori A; Kennel SJ; Huang L
Pharm Res; 1993 Apr; 10(4):507-14. PubMed ID: 8483832
[TBL] [Abstract][Full Text] [Related]
4. Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs.
Crosasso P; Brusa P; Dosio F; Arpicco S; Pacchioni D; Schuber F; Cattel L
J Pharm Sci; 1997 Jul; 86(7):832-9. PubMed ID: 9232525
[TBL] [Abstract][Full Text] [Related]
5. Development of a procedure for coupling the homing device glu-plasminogen to liposomes.
Heeremans JL; Kraaijenga JJ; Los P; Kluft C; Crommelin DJ
Biochim Biophys Acta; 1992 Oct; 1117(3):258-64. PubMed ID: 1384709
[TBL] [Abstract][Full Text] [Related]
6. Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity.
Vingerhoeds MH; Haisma HJ; Belliot SO; Smit RH; Crommelin DJ; Storm G
Pharm Res; 1996 Apr; 13(4):604-10. PubMed ID: 8710754
[TBL] [Abstract][Full Text] [Related]
7. Characterization and in vitro evaluation of nimotuzumab conjugated with cisplatin-loaded liposomes.
Vázquez-Becerra H; Pérez-Cárdenas E; Muñiz-Hernández S; Izquierdo-Sánchez V; Medina LA
J Liposome Res; 2017 Dec; 27(4):274-282. PubMed ID: 27367153
[TBL] [Abstract][Full Text] [Related]
8. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
Nam SM; Kim HS; Ahn WS; Park YS
Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
[TBL] [Abstract][Full Text] [Related]
9. Preparation of immunoliposomes bearing poly(ethylene glycol)-coupled monoclonal antibody linked via a cleavable disulfide bond for ex vivo applications.
Mercadal M; Domingo JC; Petriz J; Garcia J; de Madariaga MA
Biochim Biophys Acta; 2000 Dec; 1509(1-2):299-310. PubMed ID: 11118541
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
Ohta S; Igarashi S; Honda A; Sato S; Hanai N
Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
[TBL] [Abstract][Full Text] [Related]
11. Fc-receptor-mediated targeting of antibody-bearing liposomes containing dideoxycytidine triphosphate to human monocyte/macrophages.
Betageri GV; Black CD; Szebeni J; Wahl LM; Weinstein JN
J Pharm Pharmacol; 1993 Jan; 45(1):48-53. PubMed ID: 8094446
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells.
Koning GA; Gorter A; Scherphof GL; Kamps JA
Br J Cancer; 1999 Aug; 80(11):1718-25. PubMed ID: 10468287
[TBL] [Abstract][Full Text] [Related]
13. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
14. Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
Rubas W; Supersaxo A; Weder HG; Hartmann HR; Hengartner H; Schott H; Schwendener R
Int J Cancer; 1986 Jan; 37(1):149-54. PubMed ID: 3941019
[TBL] [Abstract][Full Text] [Related]
15. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures.
Hansen CB; Kao GY; Moase EH; Zalipsky S; Allen TM
Biochim Biophys Acta; 1995 Nov; 1239(2):133-44. PubMed ID: 7488618
[TBL] [Abstract][Full Text] [Related]
16. Antibody-labeled liposomes for CT imaging of atherosclerotic plaques: in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography.
Danila D; Partha R; Elrod DB; Lackey M; Casscells SW; Conyers JL
Tex Heart Inst J; 2009; 36(5):393-403. PubMed ID: 19876414
[TBL] [Abstract][Full Text] [Related]
17. The specificity and affinity of immunoliposome targeting to oral bacteria.
Robinson AM; Creeth JE; Jones MN
Biochim Biophys Acta; 1998 Mar; 1369(2):278-86. PubMed ID: 9518649
[TBL] [Abstract][Full Text] [Related]
18. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody.
Pan H; Niu GQ; Pan J; Lu WY
Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
Lopes de Menezes DE; Pilarski LM; Allen TM
Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
